Both in Biotechnology
Champions Oncology vs Cardiff Oncology
Over the past year CSBR returned −27.6% and CRDF returned −61.0%; their daily moves had a correlation of 0.02.
CSBR −27.6% CRDF −61.0%Growth of $1, one year, split-adjusted
| Metric | CSBR | CRDF |
|---|---|---|
| Price | $4.92 | $0.8976 |
| Market cap | $68.5M | $69.8M |
| Today | +1.86% | +2.57% |
| 1 month | +2.7% | −23.3% |
| 6 months | −15.9% | −44.6% |
| Year to date | −28.8% | −68.1% |
| 1 year | — | −60.8% |
| Revenue growth (YoY) | +8.8% | −14.0% |
| Gross margin | 50.5% | 100.0% |
| Net margin | −2.8% | −8882.7% |
| P/E (TTM) | — | — |
| Price / sales | 1.1× | 137.5× |
| Net cash | $4.4M | $34.5M |
| Dividend yield | — | — |
| Volatility (60d) | 35.8% | 71.5% |
| Short % of float | 1.5% | 17.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).